市场调查报告书
商品编码
1273568
到 2028 年的大麻种植市场预测——按产品类型、化合物、应用、分销渠道、种植类型、生物量、作物品种和地区进行的全球分析Cannabis Cultivation Market Forecasts to 2028 - Global Analysis By Product Type, Compound, Application, Distribution Channel, Cultivation Type, Biomass, Crop Variety and By Geography |
根据 Stratistics MRC 的数据,全球大麻种植市场预计将在 2022 年达到 3921 亿美元,并在 2028 年达到 13777 亿美元,在预测期内增长 23.3%。预计将以復合年增长率增长的
大麻是一种开花植物,由于其广泛认可的治疗和药用特性,已经被食用了数千年。 它也因其在社会和精神环境中的使用而闻名。 三个物种占优势:C. sativa、C. indica 和 C. ruderalis。 目前正在开发的大多数栽培品种都是结合了这些重要物种的两种或多种性状的杂交种。 此外,大麻合法化的运动正在全球范围内获得势头。 推动这一运动的是人们越来越意识到大麻具有一系列有益的医学和治疗益处。
根据 2021 年 10 月发表在《柳叶刀》杂誌上的一项研究,由于大流行,到 2020 年全球将有 5320 万例抑郁症和 7620 万例焦虑症。
随着大麻种植和消费在世界许多国家蓬勃发展,技术进步正在改革,以有效地创造基于大麻的产品。 随着越来越多的国家寻求医用大麻合法化,技术在大麻种植中的参与变得越来越重要。 传统上,大麻种植有利于对植物进行少量加工。 然而,技术的进步正在推动生产商越来越多地生产食品、胶囊、电子烟油和软糖。
大麻合法化带来了诸如增加就业和增加税收等好处,但同时也增加了大麻过量服用的风险。 过量服用会导致短期的焦虑和惊恐发作,以及长期的心律失常和精神问题。 还有一种可能是“大麻成瘾”,即一次吸食过量的大麻,导致短暂的不良反应。 有许多大麻产品出售,包括胶囊、油、各种食品和蒸发器。 由于奢侈食品的效果需要时间才能显现,因此意外大量摄入此类奢侈食品的风险更大。 由于这些对健康的负面影响,一些国家尚未使大麻合法化,阻碍了全球大麻产业的发展。
全球大麻需求的快速增长增加了对更好发展的需求。 由于这种需求,多家公司正在开展研发工作,以深入研究大麻的各种基因改造方案。 製造商最有前途的机会之一是为寻求非精神活性医用大麻的患者创造低剂量、可食用的产品。 此外,低剂量食用品是将新消费者带入大麻市场的理想产品线,因为可以通过微剂量控制娱乐用途。 大麻注入消费品业务的繁荣是由社会对大麻的接受度不断提高推动的。
种植大麻需要大量的精力和一致性。 大麻是美国大部分州和其他地区种植的能源消耗量最大的作物之一。 最大化生产需要大量的水和光,以及用于室内和室外植物生长的特殊气候控制设备。 对水的高需求会导致污染和分流,从而对生态系统产生不利影响。 它还可以直接导致土壤侵蚀。 另一方面,大麻植物可以吸收和储存重金属。 能源成本可能达到批发价格的 50%,随着大麻价格持续下跌,这一数字预计还会上升。
COVID-19 大流行对大麻市场产生了重大影响。 COVID-19 疫情影响了世界各地的多家公司。 大麻市场也是如此。 为了遏制 COVID-19 的传播,世界各国政府实施了极端限制措施,例如关闭边境、禁闭和社会隔离。 然而,在后 COVID 形势下,大麻市场有望受益。
由于大麻和大麻衍生产品的日益普及以及低 THC 水平,预计大麻部分将出现有利增长。 此外,大麻预计将成为增长最快的市场,预计在预测期内将快速扩张。 这种扩张是由于在许多国家,用于医疗和成人使用的大麻日益合法化。
由于大麻和大麻在製药、个人护理和化妆品、膳食补充剂以及食品和饮料等行业中的使用增加,预计工业消费领域在预测期内将以最快的复合年增长率增长。。 此外,在整个预测期内,公司越来越多地使用大麻及其衍生物作为原料来生产创新的大麻输液产品等因素预计将提振大麻种植市场。
由于政府法规的快速变化以及乌拉圭和智利等国家休閒大麻的合法化,南美洲预计在预测期内将占据最大的市场份额。 这种对产品的立法和监管态度的一个重要贡献者是支持合法化的社会运动。 此外,一些初创公司也开始了产品的研发和生产。
由于医用大麻使用量的增加和立法发展的进展,预计欧洲在预测期内的复合年增长率最高。 欧洲国家已证明医用大麻可用于治疗一系列疾病,从癌症到艾滋病相关疾病患者的食慾增强。 此外,由于政府政策的变化,预计对该产品的需求将飙升。 因此,由于每个国家的治疗应用增加,预计按地区划分的销售额将增加。
2022 年 5 月,Canopy Growth Corporation 推出了该公司调味大麻碳酸饮料的新口味:Orange Bit 和 Grape。 此次发布扩大了公司的产品组合,使其能够在大麻市场提供创新产品。
2022 年 3 月,Martha Stewart 与 Canopy Growth Corporation 和 Marquee Brands 合作推出了 15 种口味的 CBD Wellness Gummi Samplers。 该系列产品为消费者提供了 CBD 的健康益处。
2022年3月,Tilray medicals宣布进入马耳他共和国市场,并在马耳他共和国推出首款大麻油产品。 这将使公司能够扩大其区域影响力。
2021 年 12 月,Organigram Holdings Inc. 收购了加拿大品牌 Laurentian Organics Incorporation,这是一家获得许可的工艺大麻生产商。 通过这个品牌,我们将有助于获得强大的客户群。
2021 年 5 月,Aurora Cannabis Inc. 成立了自己的科学与创新部门,专注于为大麻素生物合成和植物遗传学的开发申请专利和将专利技术商业化。
2021 年 4 月,Canopy Growth Corporation 将收购 Supreme Cannabis Company,将该公司的优质品牌 7acres 添加到 Canopy Growth 的产品组合中,并增加一个种植低成本杂交温室大麻的设施。。 此次收购将使公司能够通过 Supreme 的优质品牌和优质产品接触更多消费者,进一步加强 Canopy 的市场领导地位。
According to Stratistics MRC, the Global Cannabis Cultivation Market is accounted for $392.1 billion in 2022 and is expected to reach $1377.7 billion by 2028 growing at a CAGR of 23.3% during the forecast period. Cannabis is a genus of flowering plants that has been consumed for thousands of years due of its widely acknowledged therapeutic and medical properties. Its use in social and spiritual contexts is likewise well documented. Three species predominate: C. sativa, C. indica, and C. ruderalis. The majority of cultivars developed now are hybrids that combine traits from two or more of these important species. Additionally, the global movement to legalise marijuana is gathering steam. The main factor fueling this momentum is the growing understanding that the product may have a variety of valid medicinal benefits and therapeutic applications.
According to research published in The Lancet in October 2021, the pandemic resulted in 53.2 million extra significant cases of depressive disorder and 76.2 million additional instances of anxiety disorders worldwide in 2020.
As cannabis cultivation and consumption become more popular in many nations around the world, technological advancement is being reformed to allow for the effective creation of cannabis-based products. As more countries strive to legalise cannabis for medical purposes, technology engagement in cannabis cultivation is becoming increasingly important. Cannabis growers have traditionally prioritised little plant processing. However, due to technical advancements, producers are increasingly focusing on producing edibles, capsules, vaping oils, and gummies.
Legalising cannabis brings benefits in terms of increased employment and tax income, but it also increases the risk of cannabis overdose. Overdosing can cause anxiety or panic attacks in the short term, as well as heart arrhythmia and mental health problems in the long term. Cannabis poisoning, or the transient harmful effects of consuming an excessive amount of cannabis at once, is also a possibility. There are numerous cannabis products available, including capsules, oils, a variety of foods, and vaporizers. Because the effects of edibles take time to manifest, there is a larger danger of mistakenly consuming a high dose of such edibles. As a result of these unfavourable health impacts, several countries are not legalising cannabis, hindering global cannabis industry growth.
The rapid expansion in global demand for cannabis has heightened the need for improved development. As a result of this necessity, several companies have developed R&D that exhaustively investigates various genetic improvement options for cannabis. One of the most promising opportunities for manufacturers is to create low-dose edible products for patients seeking medical cannabis without psychoactive effects. Furthermore, low-dose edibles are an ideal product line for attracting new consumers into the cannabis market because micro-dosing allows them to have control over their recreational usage. The rise of the cannabis-infused consumable products business is being driven by greater social acceptance of cannabis.
Cannabis plant cultivation requires a lot of energy and consistency. Cannabis is one of the most energy-intensive crops growing in the majority of US states and other areas of the world. To maximise output, a large amount of water and light are necessary, as well as specialised climate-control equipment for indoor and outdoor plant growth. The high demand for water causes contamination and diversion, which can harm the ecology. It may also contribute directly to soil erosion. Cannabis plants, on the other hand, have the potential to absorb and store heavy metals. Energy costs might amount to 50% of the wholesale price, which figure is projected to rise as cannabis prices continue to fall.
The COVID-19 pandemic has had a significant impact on the cannabis market. The COVID-19 outbreak has had an impact on a wide range of enterprises worldwide. This is also true in the Cannabis Market. To limit the spread of COVID-19, governments around the world imposed extreme restrictions such as border closures, lockdowns, and social isolation. However, in the post-COVID situation, the cannabis market is expected to benefit.
The hemp segment is estimated to have a lucrative growth, due to the increased popularity of hemp and hemp-derived goods, and because of its low THC concentration. Furthermore, marijuana is predicted to be the fastest-growing market, expanding at a rapid pace during the projection period. This expansion can be ascribed to the increasing legalisation of marijuana for medical and adult use in numerous countries.
The industrial consumption segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the increasing use of marijuana and hemp in businesses such as pharmaceuticals, personal care and cosmetics, nutraceuticals, and food and beverages. Furthermore, factors such as the increasing use of cannabis and its derivatives as raw materials by enterprises to create innovative cannabis-infused products are likely to boost the cannabis cultivation market throughout the forecast period.
South America is projected to hold the largest market share during the forecast period owing to fast changing government regulations and the legalisation of recreational hemp in countries such as Uruguay and Chile, among others. Some of the important causes that contributed to this attitude towards the product through laws and legislation were social movements in favour of legalisation. Furthermore, several new start-ups are commencing on product research, development, and production.
Europe is projected to have the highest CAGR over the forecast period, owing to the growing usage of medical cannabis and progressive legislation. Medical marijuana has been shown in trials to be useful in treating illnesses ranging from cancer to appetite stimulants in individuals with AIDS-related sickness in European countries. Furthermore, due to changes in government policy, the product's demand is predicted to skyrocket. As a result, rising therapeutic use of the substance in countries is likely to improve regional sales.
Some of the key players profiled in the Cannabis Cultivation Market include: Atlas Growers, Canopy Growth Corporation, Organigram Holding, Inc., Aphria, Inc., Pacific Cannabis Growers, Aurora Cannabis, The Hydropothecary Corp., Tilray, The Cronos Group, CannTrust Holdings, Better Holdings, Curaleaf, Green Thumb Industries, Cresco Labs, Trulieve and Medmen.
In May 2022, Canopy Growth Corporation launched new flavours for their flavoured cannabis infused carbonated drinks: orange orbit and the Grape. This launch increases the company's product portfolio and delivering innovative products in cannabis market.
In March 2022, Martha Stewart, in collaboration with Canopy Growth Corporation and Marquee Brands, released 15-flavor CBD Wellness Gummies Sampler. This range of products provided the consumer with the wellness benefits of CBD.
In March 2022, Tilray medicals announced their market entry in Malta and launch its first cannabis oil product in Malta. This will help company to expand its regional presence
In December 2021, Organigram Holdings Inc. acquired Laurentian Organics Incorporation, Canadian brand which is a craft cannabis licensed producer. It will help company in acquiring strong customer-based through this brand.
In May 2021, Aurora Cannabis Inc. launched the company's own science & innovation business unit, which mainly focus on commercializing patents and patent technology, with the development of cannabinoid biosynthesis and plant genetics.
In April 2021, Canopy Growth Corporation acquired Supreme Cannabis Company, which leads on to adding their premium brand 7acres to Canopy Growth Portfolio and the facilities of cultivating low-cost hybrid greenhouse cannabis. Due to this acquisition the company can reach more consumers through Supreme's premium brands and high-quality products, further solidifying Canopy's market leadership.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.